Kevin Flanigan, MD
Nationwide Children's Hospital
5
5
2
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Prof. Thomas Sejersen, MD, PhD
Astrid Lindgrens Barnsjukhus- Karolinska Universitetssjukhuset, SE-17176 Stockholm, Sweden
Shared therapeutic areas:
Barry Byrne, MD
University of Florida
Shared therapeutic areas:
ANANT E BAGUL, MS ORTHO
Chaitanya Hospital
Shared therapeutic areas:
Ana Camacho Salas, MD
Hospital Universitario 12 de Octubre
Shared therapeutic areas:
Bryan W. Burnette, MD
Monroe Carell Jr. Children's Hospital at Vanderbilt
Shared therapeutic areas:
Susan Sparks, MD
The Charlotte-Mecklenburg Hospital Authority, Charlotte, NC, USA
Shared therapeutic areas:
Pascal AMEDRO, MD, PhD
UH Montpellier
Shared therapeutic areas:
Michele Yang, MD
Children's Hospital Colorado
Shared therapeutic areas:
Ayşe Karaduman, Prof.
Hacettepe University
Shared therapeutic areas:
Luisa Politano, MD
Azienda Ospedaliera Universitaria della Seconda Università degli Studi di Napoli
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.
Spironolactone Versus Prednisolone in DMD
Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy
Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2
All 5 trials loaded